Technology News and Research

RSS

Facial rejuvenation to address multiple signs of aging face can be performed safely at 1 time

A total facial rejuvenation that combines three procedures to address the multiple signs of an aging face and neck can be performed safely at one time, a new study shows.

9 Sep 2014

Researchers open a kind of window into inner workings of lithium-ion battery

For the first time, researchers have been able to open a kind of window into the inner workings of a lithium-ion battery.

9 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

Researchers receive $23.8 million from CMS to improve HIV prevention and care

Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs.

8 Sep 2014

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

8 Sep 2014

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa.

8 Sep 2014

New immuno-oncology drug helps body's own immune system to fend off cancer

According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.

8 Sep 2014

Extreme environment medicine: an interview with Dr Kevin Fong, University College London

The understanding of how long-duration space flight affects the human body has come on quite considerably in recent years, and in large part, we owe that to programs of research that have taken place aboard the International Space Station and the Mir Space Station.

8 Sep 2014

Synthetic platelet-like particles could augment natural blood clotting for treatment of traumatic injuries

A new class of synthetic platelet-like particles could augment natural blood clotting for the emergency treatment of traumatic injuries - and potentially offer doctors a new option for curbing surgical bleeding and addressing certain blood clotting disorders without the need for transfusions of natural platelets.

8 Sep 2014

Researchers measure stiffness of membrane surrounding red blood cells over time

It may look like fresh blood and flow like fresh blood, but the longer blood is stored, the less it can carry oxygen into the tiny microcapillaries of the body, says a new study from University of Illinois researchers.

8 Sep 2014

Three Clemson startup companies receive $25,000 in seed money from USAP

Clemson University Research Foundation (CURF) announced that three Clemson startup companies have each received $25,000 in seed money from the University Sponsored Application Program (USAP) offered by SC Launch.

8 Sep 2014

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

PHI collaborates with Northeastern University for establishing novel cell analysis applications

Phase Holographic Imaging (PHI) today announces a collaboration agreement with Northeastern University of Boston.

8 Sep 2014

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Creating induced pluripotent stem cells or iPS cells allows researchers to establish "disease in a dish" models of conditions ranging from Alzheimer's disease to diabetes.

8 Sep 2014

Study investigates stigma as a significant barrier to care for many individuals with mental illness

Over 60 million Americans are thought to experience mental illness in a given year, and the impacts of mental illness are undoubtedly felt by millions more in the form of family members, friends, and coworkers.

8 Sep 2014

Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas

The US, which has a mostly private health-care system, manages to spend more on its public health-care system than countries where the health-care system is almost entirely public. America's government spends more, as a percentage of the economy, on public health care than Canada, the United Kingdom, Japan or Australia. And then it spends even more than that on private health care.

5 Sep 2014

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Tinnitus, migraine, epilepsy, depression, schizophrenia, Alzheimer's: all these are examples of diseases with neurological causes, the treatment and study of which is more and more frequently being carried out by means of magnetic stimulation of the brain. However, the method's precise mechanisms of action have not, as yet, been fully understood.

5 Sep 2014

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Porvair Sciences has published an informative 8-page brochure providing scientists with a background to Chromatin Immunoprecipitation (ChIP), an introduction to Chromatrap® ChIP assay technology and how Chromatrap® compares to traditional bead based methodologies.

From Chromatrap® - Porvair Sciences Ltd 4 Sep 2014

FDA provides QIDP designation to Debiopharm’s Debio 1450 for treatment of ABSSSI

Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

4 Sep 2014

Technology News and Research

Facial rejuvenation to address multiple signs of aging face can be performed safely at 1 time

Researchers open a kind of window into inner workings of lithium-ion battery

Canada funds 22 inventive ideas for improving health in low-resource countries

Researchers receive $23.8 million from CMS to improve HIV prevention and care

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

New immuno-oncology drug helps body's own immune system to fend off cancer

Extreme environment medicine: an interview with Dr Kevin Fong, University College London

Synthetic platelet-like particles could augment natural blood clotting for treatment of traumatic injuries

Researchers measure stiffness of membrane surrounding red blood cells over time

Three Clemson startup companies receive $25,000 in seed money from USAP

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Soligenix acquires novel orphan drug candidate for treatment of CTCL

PHI collaborates with Northeastern University for establishing novel cell analysis applications

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Study investigates stigma as a significant barrier to care for many individuals with mental illness

Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas

Researchers demonstrate neuronal effects of novel treatment method for neurological diseases

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

FDA provides QIDP designation to Debiopharm’s Debio 1450 for treatment of ABSSSI

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News